TNDM / Tandem Diabetes (TNDM) Releases Favorable Data on t:slim X2

Tandem Diabetes Care, Inc. (NASDAQ:TNDM ) Q3 2023 Earnings Conference Call November 1, 2023 4:30 PM ET Company Participants Susan Morrison - EVP & Chi more_horizontal

Although the revenue and EPS for Tandem Diabetes Care, Inc. (TNDM) give a sense of how its business performed in the quarter ended September 2023, it more_horizontal

Tandem Diabetes Care, Inc. (TNDM) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions more_horizontal

Investors remain optimistic about Tandem Diabetes (TNDM), backed by strategic developments and innovative new launches. more_horizontal

Investors continue to be optimistic about Tandem Diabetes (TNDM) due to the t:slim X2 insulin pump and new product innovations. more_horizontal

Tandem Diabetes' (TNDM) second-quarter 2023 performance reflects new technology innovations and operational improvements throughout its business. more_horizontal

Although the revenue and EPS for Tandem Diabetes Care, Inc. (TNDM) give a sense of how its business performed in the quarter ended June 2023, it might more_horizontal

Tandem Diabetes Care, Inc. (TNDM) came out with a quarterly loss of $0.30 per share versus the Zacks Consensus Estimate of a loss of $0.54. This compa more_horizontal